Insight Molecular Diagnostics Inc. (IMDX) Financials

$2.59

$0.11 (4.44%)
Last update: 04:00 PM EST
Day's range
$2.49
Day's range
$2.6
$20M$20M$0$0-$20M-$20M-$40M-$40M-$60M-$60M-$80M-$80MEarning201820182019201920202020202120212022202220232023202420242000%2000%0%0%-2000%-2000%-4000%-4000%-6000%-6000%-8000%-8000%Profit Margin
Profit Margin
Revenue
Earnings

IMDX Income statement / Annual

Last year (2024), Insight Molecular Diagnostics Inc.'s total revenue was $1.88 M, an increase of 25.15% from the previous year. In 2024, Insight Molecular Diagnostics Inc.'s net income was -$60.66 M. See Insight Molecular Diagnostics Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $1.88 M $1.50 M $958.00 K $2.20 M $1.22 M $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $1.14 M $1.09 M $976.00 K $7.54 M $1.86 M $344.00 K $559.00 K $580.00 K $387.00 K $283.00 K
Gross Profit $740.00 K $501.00 K $78.00 K $188.00 K -$639.00 K -$344.00 K -$559.00 K -$580.00 K -$387.00 K -$283.00 K
Gross Profit Ratio 0.39 0.33 0.08 0.09 -0.53 0 0 0 0 0
Research and Development Expenses $9.84 M $9.29 M $7.30 M $13.63 M $9.80 M $6.79 M $6.51 M $7.17 M $5.68 M $4.53 M
General & Administrative Expenses $13.14 M $10.74 M $21.88 M $22.34 M $16.79 M $13.28 M $7.01 M $9.23 M $5.46 M $4.19 M
Selling & Marketing Expenses $641.00 K $2.80 M $1.13 M $11.17 M $6.49 M $2.16 M $1.68 M $2.44 M $0.00 $0.00
Selling, General & Administrative Expenses $13.79 M $13.54 M $23.01 M $33.50 M $23.28 M $15.45 M $8.69 M $11.68 M $5.46 M $4.19 M
Other Expenses $38.16 M $2.81 M -$12.24 M $0.00 -$4.01 M $0.00 $91.00 K $0.00 $0.00 $2.00 K
Operating Expenses $61.78 M $25.64 M $18.08 M $47.13 M $29.07 M $22.24 M $15.20 M $18.85 M $11.14 M $8.72 M
Cost And Expenses $62.92 M $26.64 M $18.96 M $55.92 M $30.93 M $22.24 M $15.20 M $18.85 M $11.14 M $8.72 M
Interest Income $0.00 $0.00 $0.00 $0.00 $0.00 $299.00 K $0.00 $0.00 $0.00 $0.00
Interest Expense $84.00 K $52.00 K $83.00 K $209.00 K $252.00 K $299.00 K $216.00 K $217.00 K $28.00 K $19.00 K
Depreciation & Amortization $1.56 M $1.68 M $5.22 M $4.21 M $394.00 K $344.00 K $559.00 K $580.00 K $387.00 K $283.00 K
EBITDA -$59.02 M -$23.12 M -$13.32 M -$48.46 M -$30.54 M -$21.90 M -$15.20 M -$18.27 M -$11.14 M -$8.44 M
EBITDA Ratio -31.37 -15.38 -13.9 -22.05 -25.12 0 0 0 0 0
Operating Income Ratio -32.45 -16.72 -18.79 -10.82 -24.43 0 0 0 0 0
Total Other Income/Expenses Net $378.00 K $281.00 K -$615.00 K $854.00 K -$1.48 M -$187.00 K -$552.00 K -$526.00 K -$28.00 K -$17.00 K
Income Before Tax -$60.66 M -$24.86 M -$18.61 M -$52.87 M -$31.19 M -$22.43 M -$15.75 M -$19.38 M -$11.17 M -$8.74 M
Income Before Tax Ratio -32.25 -16.54 -19.43 -24.05 -25.65 0 0 0 0 0
Income Tax Expense $0.00 $0.00 $0.00 -$9.26 M -$1.25 M -$97.00 K $0.00 $0.00 $0.00 $0.00
Net Income -$60.66 M -$27.78 M -$72.90 M -$64.10 M -$29.93 M -$22.33 M -$15.75 M -$19.38 M -$11.17 M -$8.74 M
Net Income Ratio -32.25 -18.48 -76.1 -29.16 -24.62 0 0 0 0 0
EPS -4.66 -3.75 -13.25 -14.42 -9.14 -8.71 -8.32 -12.83 -8.42 -8.32
EPS Diluted -4.66 -3.75 -13.25 -14.42 -9.14 -8.71 -8.32 -12.83 -8.42 -8.32
Weighted Average Shares Out $13.07 M $7.65 M $5.54 M $4.45 M $3.27 M $2.56 M $1.89 M $1.51 M $1.33 M $1.05 M
Weighted Average Shares Out Diluted $13.07 M $7.65 M $5.54 M $4.45 M $3.27 M $2.56 M $1.89 M $1.51 M $1.33 M $1.05 M
Link